Margaux Hall

Partner at Gibson Dunn & Crutcher LLP

Speaker

Margaux Hall is a partner in the Washington, D.C. office of Gibson Dunn and a member of the firm’s FDA and Health Care practice.

Margaux is a leading lawyer in drug pricing, coverage, reimbursement, market access, and value-based arrangements. She brings to clients a keen understanding of the transformative legal, policy, and changes affecting pricing and access to drugs, vaccines and devices, including in government enforcement and litigation matters. Margaux provides sophisticated legal and strategic business counsel to pharmaceutical manufacturers, investors, and others in the healthcare and life sciences sector on regulatory, transactional, and government enforcement matters. Her expertise spans topics of pricing, coverage, and reimbursement under Medicare Advantage-Part D, Medicaid, the Federal Supply Schedule, and commercial insurance, and government price reporting laws. Margaux advises on the evolving landscape for drug development and commercialization in connection with the Inflation Reduction Act, Most Favored Nation reforms and direct-to-patient commercialization channels.

Margaux has dedicated her career to understanding and promoting access to health care in the United States and worldwide. After graduating from Harvard Law School, she pursued a Fulbright Fellowship to research health care law and health system reform in South Africa and then later led similar research programs at the World Bank. She also completed a post-graduate fellowship in health law at Columbia Law School.

Education

· JD, cum laude, Harvard Law School; Managing Editor of the Harvard Journal of Law & Technology

· BS (Management Science & Engineering, and honors in Civil Engineering), with distinction, Stanford University; Phi Beta Kappa

Admissions

· District of Columbia, 2016

· New York, 2009

· U.S. District Court for the District of Columbia